89Sr联合放疗治疗骨转移瘤的研究进展  

Progress of external beam radiotherapy combined with 89Sr in the treatment of bone metastases

作　　者：武凯丽 白侠[2] 赵建国[1] Kaili;Bai Xia;Zhao Jianguo(Department of Radiotherapy,Affiliated Hospital of Inner Mongolia Medical University,Hohhot 010050,China;Department of Nuclear Medicine,Affiliated Hospital oflnner Mongolia Medical Univer-sity,Hohhot 010050,China)

机构地区：[1]内蒙古医科大学附属医院放疗科,呼和浩特010050 [2]内蒙古医科大学附属医院核医学科,呼和浩特010050

出　　处：《中华核医学与分子影像杂志》2018年第9期636-638,共3页Chinese Journal of Nuclear Medicine and Molecular Imaging

基　　金：中华医学会核医学分会多中心研究项目

摘　　要：骨骼为恶性肿瘤最常见的转移部位之一，由此引起的骨痛、病理性骨折和脊髓压迫等骨相关事件会严重影响肿瘤患者的生活质量。骨转移瘤的治疗呈多样化，放疗与89Sr为常用的治疗手段，但单一的治疗方式并不能取得满意的疗效。该文综述了89Sr联合放疗治疗骨转移瘤的研究进展。Skeleton is one of the most common metastasis sites of malignant tumor. Bone metastases can cause bone pain, pathologic fractures, spinal cord compression and other bone related events, which seriously affect the quality of life of patients. The treatment modalities of bone metastases are diverse. External beam radiotherapy and 89Sr are commonly used in the treatment of bone metastases, however, a single treatment cannot achieve satisfactory results. This review summarizes the advances of 89Sr combined with external beam radiotherapy for bone metastases.

关 键 词：肿瘤转移 骨骼 放射疗法 锶放射性同位素 发展趋势 

分 类 号：R738.1[医药卫生—肿瘤]